Last updated on February 2018

A Single Escalating Dose and Multiple Dose Study of BAY 1093884 in Subjects With Severe Hemophilia Types A or B With or Without Inhibitors


Brief description of study

Investigate the safety, tolerability and pharmacokinetics of BAY1093884 after Intravenous (IV) and subcutaneous (SC) administration of increasing single doses and SC administration of multiple doses.

Clinical Study Identifier: NCT02571569

Contact Investigators or Research Sites near you

Start Over